Publication | Open Access
Inhibition of Homologous Recombination in Human Cells by Targeting RAD51 Recombinase
146
Citations
43
References
2012
Year
Gene TherapiesGenome InstabilityDna DamageHuman CellsHomologous RecombinationNatural SciencesRad51 RecombinaseDna ReplicationMolecular BiologyChromosomal RearrangementCancer CellsRecombination DynamicTumor SuppressorAnti-cancer AgentMedicineCell BiologyCompound 1
The homologous recombination (HR) pathway plays a crucial role in the repair of DNA double-strand breaks (DSBs) and interstrand cross-links (ICLs). RAD51, a key protein of HR, possesses a unique activity: DNA strand exchange between homologous DNA sequences. Recently, using a high-throughput screening (HTS), we identified compound 1 (B02), which specifically inhibits the DNA strand exchange activity of human RAD51. Here, we analyzed the mechanism of inhibition and found that 1 disrupts RAD51 binding to DNA. We then examined the effect of 1 on HR and DNA repair in the cell. The results show that 1 inhibits HR and increases cell sensitivity to DNA damage. We propose to use 1 for analysis of cellular functions of RAD51. Because DSB- and ICL-inducing agents are commonly used in anticancer therapy, specific inhibitors of RAD51 may also help to increase killing of cancer cells.
| Year | Citations | |
|---|---|---|
Page 1
Page 1